Gwen A Melincoff Collegium Pharmaceutical, Inc (COLL) insider trading activity

COLL Quotes by TradingView

Gwen A Melincoff is Director of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 52,468 shares of COLL, which is worth approximately $2.03 Million. The most recent transaction as insider was on May 16, 2024, when has been sold 7,693 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.5K
0% 3M change
17.18% 12M change
Total Value Held $2.03 Million

Gwen A Melincoff Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2024
BUY
Grant, award, or other acquisition
-
7,693 Added 12.79%
52,468 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
-
9,792 Added 17.94%
44,775 Common Stock
May 19 2022
BUY
Grant, award, or other acquisition
-
14,035 Added 28.63%
34,983 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
-
9,941 Added 32.18%
20,948 Common Stock

Also insider at

SLNO
SOLENO THERAPEUTICS INC Healthcare
Director
PLX
Protalix BioTherapeutics, Inc. Healthcare
GANX
Gain Therapeutics, Inc. Healthcare
Director
GAM

Gwen A Melincoff

Director
Carmiel, L3

Track Institutional and Insider Activities on COLL

Follow COLLEGIUM PHARMACEUTICAL, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on COLL